文献速递慢性静脉疾病

血管外科学会与美国静脉论坛关于2016年7月20日Medicare证据开发与覆盖咨询委员会下肢慢性静脉疾病专家小组会议的报道

Report of the Society for Vascular Surgery and the American Venous Forum on the July 20, 2016 meeting of the Medicare Evidence Development and Coverage Advisory Committee panel on lower extremity chronic venous disease.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2017-01-01

2016年7月20日,Medicare证据开发与覆盖咨询委员会专家小组评估了当前下肢慢性静脉疾病(CVD)治疗措施的获益与风险及其对美国成人健康结局的影响。会议旨在为美国医疗保险和医疗补助服务中心(CMS)的覆盖决策提供建议,基于AHRQ系统评价、专家讲座和公开听证,专家小组对关键问题进行了投票。本报告总结了支持血管外科学会/美国静脉论坛联盟建议的证据,并讨论了静脉疾病证据缺口、治疗差异及CMS可支持的改善证据基础的机制。

要点

  • 专家小组评估了现有下肢CVD治疗对健康结局的影响,为CMS覆盖决策提供建议。
  • 会议基于AHRQ系统评价、专家讲座和公开听证,对关键问题进行了投票。
  • 报告聚焦静脉疾病证据缺口、治疗差异及改善证据基础的机制。

核心结论

  • 专家小组就下肢慢性静脉疾病治疗的获益与风险及健康结局影响进行了评估,并投票形成建议以支持CMS覆盖决策。

研究设计与样本

  • Medicare证据开发与覆盖咨询委员会专家小组会议,基于AHRQ系统评价、受邀专家讲座及公开听证,并对关键问题进行投票。

主要发现

  • 会议识别了静脉疾病的重要证据缺口尚未充分解决。
  • 会议讨论了静脉疾病治疗差异及其可能对Medicare受益人健康结局的影响。
  • 会议探讨了CMS可支持的改善证据基础以优化下肢CVD患者照护的机制。

临床怎么用

  • 临床应关注下肢CVD治疗证据缺口及治疗差异对患者结局的影响。
  • 血管外科学会/美国静脉论坛联盟的建议可参考本报告总结的证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

On July 20, 2016, a Medicare Evidence Development and Coverage Advisory Committee panel assessed the benefits and risks of currently used lower extremity chronic venous disease (CVD) treatments and their effects on health outcome of the American adult population. The main purpose of the meeting was to advise the Centers for Medicare & Medicaid Services on coverage determination for interventions used for treatment of CVD. A systematic review of the Agency for Healthcare Research and Quality was presented, followed by lectures of invited experts and a public hearing of representatives of professional societies and the industry. After discussing critical issues, the panel voted for key questions. This report summarizes the presented evidence to support recommendations of the Society for Vascular Surgery/American Venous Forum coalition and the presentations on selected discussion topics. These included important venous disease evidence gaps that have not been sufficiently addressed, venous disease treatment disparities and how they may affect the health outcomes of Medicare beneficiaries, and mechanisms that might be supported by the Centers for Medicare & Medicaid Services to improve the evidence base to optimize the care of patients with lower extremity CVD.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Gloviczki P, Dalsing MC, Henke P, et al. Report of the Society for Vascular Surgery and the American Venous Forum on the July 20, 2016 meeting of the Medicare Evidence Development and Coverage Advisory Committee panel on lower extremity chronic venous disease. J Vasc Surg Venous Lymphat Disord. 2017. PMID: 28411706. doi:10.1016/j.jvsv.2017.02.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。